UHMK1 and hepatocellular carcinoma: Next, to examine whether UHMK1 indeed served as a downstream effector of COX5B in modulating hepatoma progression, the rescue experiment was conducted by overexpressing UHMK1 in cells with or without siRNA knockdown of COX5B (Figure 7A).